DUBLIN--(BUSINESS WIRE)--The "Global & Asia Pacific High Throughput Screening Market Outlook 2030" report has been added to ResearchAndMarkets.com's offering.

The market is estimated to garner a revenue of close to USD 36230 Million by the end of 2030, up from a revenue of around USD 16290 Million in the year 2020.

The global high-throughput screening (HTS) market is anticipated to grow with a CAGR of 8.4% during the forecast period, i.e., 2021-2030.

High-throughput screening (HTS) is a drug discovery process that is used to analyze chemical and biological compounds. The HTS process involves consumables, instruments, software, and services to identify biological compounds and other biological interactions.

Factors such as the increasing healthcare expenditure, along with the growing concern for the prevalence of chronic diseases worldwide, and the increasing focus of pharmaceutical and biotechnology companies to develop advanced medicines are expected to contribute to the market growth.

The global high-throughput screening market is segmented into numerous segments which include segmentation by products & services, technology, application, end-user, and by region. The products & services segment is further divided into consumables, instruments, software, and services, out of which, the consumables segment is projected to grow with the highest CAGR of over 8% during the forecast period. In the year 2020, the segment registered a revenue of about USD 6940 Million, and is further projected to cross USD 15670 Million by the end of 2030.

On the basis of geographical analysis, the global high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is expected to attain the largest revenue of USD 15720 Million approximately by the end of 2030.

Amongst the countries in the region, the market in the United States is projected to grow with the highest CAGR of around 9% during the forecast period and also hold the largest market share by the end of 2030.

Some of the prominent industry leaders in the global high-throughput screening (HTS) market are

• Agilent Technologies Inc.
• Thermo Fisher Scientific
• Tecan Trading AG
• Promega Corporation
• Hamilton Company
• BPS Bioscience Inc.
• PerkinElmer Inc.
• Merck KGaA
• Carna Biosciences Inc.
• Danaher Corporation

Key Topics Covered:

1. Market Definition and Research Methodology

2. Executive Summary

3. Industry Value Chain Analysis

4. Market Dynamics

5. Regulatory & Standards Landscape

6. Industry Risk Analysis

7. Growth Opportunity Analysis for Business Development

8. Impact of COVID-19 on the Global High-Throughput Screening Market

9. Average Pricing Analysis

10. Comparative Analysis

11. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/cu9xo6

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900